With Cell & Gene Therapy Insights, Ori’s CCO Thomas Heathman, and Senior Scientist Hamza Patel, spoke at our webinar on Tuesday, June 10, at 11:00 EDT.
The webinar showcased how IRO’s flexible mixing modes enable customizable, scalable manufacturing processes that adapt to therapeutic needs and accelerate product development.
Thomas and Hamza explored:
- How early automation integration reduces manual labor, eliminates tubing, bags, and pumps, traditional hardware, and shortens manufacturing timelines by up to 25%
- How flexible mixing modes and fluid dynamic driven optimization can improve yield, transduction efficiency, and overall biological performance
- Real-world case studies that provided insights into optimizing manufacturing processes, achieving higher cell yields, improving transduction efficiency, and delivering consistent batch-to-batch performance